In this Issue:
Intensive therapy and ocular surgery in type 1 diabetes
Sitagliptin and CV outcomes in type 2 diabetes
Cost-effectiveness of CSIIs vs. MDIs in type 1 diabetes
Beloranib for weight loss in obese adults
Long-term glycaemic control and CV outcomes in type 2 diabetes
Upper GI motility and symptoms
Canagliflozin and bodyweight in relation to HbA1c and BP changes
Childhood serious life events increase risk of type 1 diabetes
Long-term type 2 diabetes risk in gestational diabetes
Imeglimin and insulin secretion/β-cell function in type 2 diabetes
Please login below to download this issue (PDF)